Braham Shroot
Senior Scientific Advisor SOLTEGO
Seminars
Thursday 21st May 2026
Salt Inducible Kinase Inhibitors: A Novel Approach for Next-Generation Topical Therapies
2:00 pm
- Explore the potential of proprietary topical SIK inhibitors supported by in vitro, ex vivo, and early human data to deliver differentiated Topical Therapies
- Discover how bioassays and skin penetration studies are enabling targeted topical delivery with favorable safety and pharmacologic properties to profile potential therapeutic indications
- Learn how integrated pharmacology, toxicology, and transcriptomic approaches are being used to de-risk next-generation therapeutics before full development
